EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Fine-tuning the cytotoxicity of ruthenium( ii ) arene compounds to enhance selectivity against breast cancers

Sarah A P Pereira, Jan Romano-deGea, Ana Isabel Barbosa, Sofia A Costa Lima, Paul J Dyson, M Lúcia M F S Saraiva

Dalton Transactions · 2023

DOI: 10.1039/d3dt02037a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dalton Transactions, 2023. Verfasst von Sarah A P Pereira und 5 weiteren Autor:innen. Beteiligte Einrichtung: LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, no 228, 4050-313 Porto, …. Hauptthemen laut MEDLINE: Organometallic Compounds, Ruthenium, Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Ministério da Ciência, Tecnologia e Ensino Superior, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A ruthenium(ii) arene compound was identified as the most promising candidate for breast cancer treatment amongst a library of rationally designed and fully synthesized compounds where the impact of different counterions’ cytotoxicity was evaluated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Organometallic CompoundsRutheniumBreast NeoplasmsAntineoplastic AgentsCoordination ComplexesHumansFemaleTolueneCell Line, Tumor

Substanzen

Organometallic CompoundsRutheniumAntineoplastic AgentsTolueneCoordination Complexes

Autor:innen und Institutionen

  • LAQV, REQUIMTE, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Rua Jorge Viterbo Ferreira, no 228, 4050-313 Porto, Portugal. lsaraiva@ff.up.pt.
  • Institut des Sciences et Ingénierie Chimiques, École Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland. paul.dyson@epfl.ch.

Förderung

  • Fundação para a Ciência e a Tecnologia
  • Ministério da Ciência, Tecnologia e Ensino Superior
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Pereira, S. A. P., Romano-deGea, J., Barbosa, A. I., Costa Lima, S. A., Dyson, P. J., & Saraiva, M. L. M. F. S. (2023). Fine-tuning the cytotoxicity of ruthenium( ii ) arene compounds to enhance selectivity against breast cancers. Dalton Transactions. https://doi.org/10.1039/d3dt02037a

Vancouver

Pereira SAP, Romano-deGea J, Barbosa AI, Costa Lima SA, Dyson PJ, Saraiva MLMFS. Fine-tuning the cytotoxicity of ruthenium( ii ) arene compounds to enhance selectivity against breast cancers. Dalton Transactions. 2023. doi:10.1039/d3dt02037a

BibTeX
@article{Pereira2023,
  author = {Pereira, Sarah A P and Romano-deGea, Jan and Barbosa, Ana Isabel and Costa Lima, Sofia A and Dyson, Paul J and Saraiva, M Lúcia M F S},
  title = {Fine-tuning the cytotoxicity of ruthenium( ii ) arene compounds to enhance selectivity against breast cancers},
  journal = {Dalton Transactions},
  year = {2023},
  doi = {10.1039/d3dt02037a}
}
Kostenlos starten →